Zacks Investment Research downgraded shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from a hold rating to a sell rating in a research report sent to investors on Monday.

According to Zacks, “In last three months, shares of Acadia Healthcare have lost value. But the company suffers from high debt, escalating interest expenses. Acadia Healthcare’s growing international operations expose it to foreign currency rate fluctuations. Its balance sheet is highly leveraged. The company's long-term debt has increased consistently for the past many years, leading to an increase in interest expense. Substantial integration risks associated with its frequent acquisitions are major headwinds.”

Other equities research analysts have also issued reports about the company. BidaskClub lowered Acadia Healthcare from a hold rating to a sell rating in a research note on Friday, August 18th. William Blair began coverage on Acadia Healthcare in a research report on Tuesday, July 18th. They set an outperform rating on the stock. Deutsche Bank AG upped their target price on Acadia Healthcare from $58.00 to $60.00 and gave the company a buy rating in a report on Monday, July 31st. UBS AG reiterated a positive rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Finally, Craig Hallum reiterated a buy rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $56.55.

Shares of Acadia Healthcare (NASDAQ ACHC) opened at 47.61 on Monday. Acadia Healthcare has a one year low of $32.54 and a one year high of $54.34. The firm has a market cap of $4.18 billion, a PE ratio of 523.19 and a beta of 1.07. The firm’s 50-day moving average price is $47.13 and its 200-day moving average price is $46.16.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm’s revenue was down 5.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.73 earnings per share. Equities research analysts expect that Acadia Healthcare will post $2.45 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/03/acadia-healthcare-company-inc-achc-downgraded-to-sell-at-zacks-investment-research.html.

In other Acadia Healthcare news, insider Scott Schwieger sold 2,891 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $52.85, for a total value of $152,789.35. Following the transaction, the insider now owns 8,841 shares in the company, valued at approximately $467,246.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director William Grieco sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the transaction, the director now owns 45,013 shares in the company, valued at approximately $2,327,622.23. The disclosure for this sale can be found here. Insiders sold 3,135,693 shares of company stock valued at $160,231,099 over the last three months. 11.10% of the stock is owned by insiders.

Several large investors have recently modified their holdings of ACHC. BlackRock Inc. grew its holdings in shares of Acadia Healthcare by 65.6% during the 2nd quarter. BlackRock Inc. now owns 8,523,077 shares of the company’s stock valued at $420,871,000 after acquiring an additional 3,377,291 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 8.9% in the second quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock worth $308,849,000 after acquiring an additional 511,299 shares during the last quarter. Aristotle Capital Management LLC acquired a new position in shares of Acadia Healthcare in the first quarter worth $140,071,000. FMR LLC increased its stake in shares of Acadia Healthcare by 26.4% in the second quarter. FMR LLC now owns 2,775,451 shares of the company’s stock worth $137,052,000 after acquiring an additional 580,449 shares during the last quarter. Finally, Frontier Capital Management Co. LLC increased its stake in shares of Acadia Healthcare by 11.5% in the second quarter. Frontier Capital Management Co. LLC now owns 2,328,063 shares of the company’s stock worth $114,960,000 after acquiring an additional 240,975 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.